DNA Hemophilia A Mutation Screen
Also Known as (Alias) | HemA Genotyping; F8 Genotyping |
Method | Polymerase Chain Reaction (PCR) Based |
Test Information | Severe patients that are negative for the DNA Factor VIII inversion or patients that have moderate or mild hemophilia can be evaluated for mutations. Through our current screening methods, a mutation is found ~90-95% of the time.
Reference mutation databases: If the specific mutation cannot be identified, intragenic linkage is often useful to trace the affected allele through the family tree by following 5 polymorphic sites. Linkage studies also help identify the de novo origin of mutations in families with an isolated occurrence (eg: maternal grandparents). Intragenic linkage may be useful in 80-90% of families where key family members (patient and both parents of potential carrier) are available. |
Additional Test Information | For approximately half of the severe hemophilia A patients (and moderate cases with FVIII levels of ~1%), the DNA Factor VIII Inversion will be negative. For these patients, along with the moderate and mild patients, the Hemophilia A Mutation Evaluation will be performed to identify the mutation. A MDE (mutation detection enhancement) screen will be performed initially and if needed, will be followed by a sequence screen. Once identified, the genotype will be tested by confirmation analysis.
Confirmation is performed one of two ways. If the mutation creates/removes a restriction enzyme digestion site, the testing will be performed by RFLP. If a restriction enzyme digestion site is not present, testing will be done by sequencing the exon in which the mutation is located. |
Sample Requirements | EDTA (lavender top) |
Requested Volume | 3-10cc EDTA (lavender top) tube
Analysis of amniocytes can be performed on cultured amniocytes. Two T-25 flasks of cells cultured to confluency will be accepted. Bloodworks Northwest does not have facilities to culture amniocytes. |
Shipping Information | Whole blood shipped at 4oC or ambient temperature is acceptable and should arrive in the lab within 48 hours.
Send samples to: Send cultured amniocyte samples to: For additional information, please see Ordering Information-Bleeding Disorders |
Requisition Form | Request for Testing Eastlake Bleeding Disorders Laboratory |
Transaction Code | 3250-02 |
CPT Codes | 81407 |
Turn around Time (analytic time) | 2-4 weeks |
Report/Results | Fax number required to receive report |